-
1
-
-
0003631066
-
Cytochrome P450: Structure, Mechanism, and Biochemistry
-
New York: Plenum
-
Ortiz de Montellano P.R. Cytochrome P450: Structure, Mechanism, and Biochemistry. second ed. 1995;Plenum, New York.
-
(1995)
Second Ed.
-
-
Ortiz De Montellano, P.R.1
-
2
-
-
0342399214
-
Mechanism of inhibition of adrenal steroid 11-beta-hydroxylase by methyrapone (metopirone)
-
Dominguez O.V., Samuels L.T. Mechanism of inhibition of adrenal steroid 11-beta-hydroxylase by methyrapone (metopirone). Endocrinology. 73:1963;304-309.
-
(1963)
Endocrinology
, vol.73
, pp. 304-309
-
-
Dominguez, O.V.1
Samuels, L.T.2
-
3
-
-
0342834498
-
Inhibitors of cytochrome P450 and possibilities for their therapeutic application
-
K. Ruckpaul. Berlin: Akademie-Verlag
-
Correia M.A., Ortiz de Montellano P.R. Inhibitors of cytochrome P450 and possibilities for their therapeutic application. Ruckpaul K. Biotransformation. 1993;74-146 Akademie-Verlag, Berlin.
-
(1993)
Biotransformation
, pp. 74-146
-
-
Correia, M.A.1
Ortiz De Montellano, P.R.2
-
4
-
-
0037041192
-
New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives
-
Pouget C., Fagnere C., Basly J.-P., Habrioux G., Chulia A.-J. New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives. Bioorg. Med. Chem. Lett. 12:2002;1059-1061.
-
(2002)
Bioorg. Med. Chem. Lett.
, vol.12
, pp. 1059-1061
-
-
Pouget, C.1
Fagnere, C.2
Basly, J.-P.3
Habrioux, G.4
Chulia, A.-J.5
-
8
-
-
0033751381
-
Mechanism of action of niacin on lipoprotein metabolism
-
Kamanna V.S., Kashyab M.L. Mechanism of action of niacin on lipoprotein metabolism. Curr. Atheroscl. Rep. 2:2000;36-46.
-
(2000)
Curr. Atheroscl. Rep.
, vol.2
, pp. 36-46
-
-
Kamanna, V.S.1
Kashyab, M.L.2
-
9
-
-
0020333654
-
High-performance liquid chromatographic determination of nicotinic acid and its metabolites, nicotinuric acid and nicotinamide, in plasma
-
Takikawa K., Miyazaki K., Arita T. High-performance liquid chromatographic determination of nicotinic acid and its metabolites, nicotinuric acid and nicotinamide, in plasma. J. Chromatogr. 233:1982;343-348.
-
(1982)
J. Chromatogr.
, vol.233
, pp. 343-348
-
-
Takikawa, K.1
Miyazaki, K.2
Arita, T.3
-
10
-
-
0028343111
-
Fluvastatin with and without niacin for hypercholesterolemia
-
Jacobson T.A., Chin M.M., Fromell G.J., Jokubaitis L.A., Amorosa L.F. Fluvastatin with and without niacin for hypercholesterolemia. Am. J. Cardiol. 74:1994;149-154.
-
(1994)
Am. J. Cardiol.
, vol.74
, pp. 149-154
-
-
Jacobson, T.A.1
Chin, M.M.2
Fromell, G.J.3
Jokubaitis, L.A.4
Amorosa, L.F.5
-
11
-
-
0029704073
-
Fluvastatin in combination with other lipid-lowering agents
-
Jokubaitis L.A. Fluvastatin in combination with other lipid-lowering agents. Br. J. Clin. Pract. Suppl. 77:1996;28-32.
-
(1996)
Br. J. Clin. Pract. Suppl.
, vol.77
, pp. 28-32
-
-
Jokubaitis, L.A.1
-
12
-
-
0038061606
-
Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the brain
-
Maiese K., Chong Z.Z. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol. Sci. 24:2003;228-232.
-
(2003)
Trends Pharmacol. Sci.
, vol.24
, pp. 228-232
-
-
Maiese, K.1
Chong, Z.Z.2
-
13
-
-
0036254579
-
Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury
-
Chong Z.Z., Lin S., Maiese K. Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J. Vasc. Res. 39:2002;131-147.
-
(2002)
J. Vasc. Res.
, vol.39
, pp. 131-147
-
-
Chong, Z.Z.1
Lin, S.2
Maiese, K.3
-
14
-
-
0032750720
-
Niacin as a potential AIDS preventive factor
-
Murray M.F. Niacin as a potential AIDS preventive factor. Med. Hypotheses. 53:1999;375-379.
-
(1999)
Med. Hypotheses
, vol.53
, pp. 375-379
-
-
Murray, M.F.1
-
15
-
-
0035032365
-
Development of a miniaturized 384-well high throughput screen for the detection of substrates of cytochrome CYP2D6 and CYP3A4 metabolism
-
Kariv I., Fereshteh M.P., Oldenburg K.R. Development of a miniaturized 384-well high throughput screen for the detection of substrates of cytochrome CYP2D6 and CYP3A4 metabolism. J. Biomol. Screen. 6:2001;91-99.
-
(2001)
J. Biomol. Screen.
, vol.6
, pp. 91-99
-
-
Kariv, I.1
Fereshteh, M.P.2
Oldenburg, K.R.3
-
16
-
-
0035192944
-
Differential inhibition and inactivation of human P450 enzymes by trans-resveratrol: Evidence for mechanism-based inactivation of CYP1A2
-
Chang T.K.H., Chen J., Lee W.B.K. Differential inhibition and inactivation of human P450 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299:2001;874-882.
-
(2001)
J. Pharmacol. Exp. Ther.
, vol.299
, pp. 874-882
-
-
Chang, T.K.H.1
Chen, J.2
Lee, W.B.K.3
-
17
-
-
0037232813
-
Studies on the inhibition of human cytochromes P450 by selenocysteine Se-conjugate
-
Venhorst J., Rooseboom M., Vermeulen N.P.E., Commandeur J.N.M. Studies on the inhibition of human cytochromes P450 by selenocysteine Se-conjugate. Xenobiotica. 33:2003;57-72.
-
(2003)
Xenobiotica
, vol.33
, pp. 57-72
-
-
Venhorst, J.1
Rooseboom, M.2
Vermeulen, N.P.E.3
Commandeur, J.N.M.4
-
18
-
-
0033694566
-
Fluorometric high-throughput screening for inhibitors of cytochrome P450
-
Miller V.P., Stresser D.M., Blanchard A.P., Turner S., Crespi C.L. Fluorometric high-throughput screening for inhibitors of cytochrome P450. Ann. N. Y. Acad. Sci. 919:2000;26-32.
-
(2000)
Ann. N. Y. Acad. Sci.
, vol.919
, pp. 26-32
-
-
Miller, V.P.1
Stresser, D.M.2
Blanchard, A.P.3
Turner, S.4
Crespi, C.L.5
-
19
-
-
0035912853
-
Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: Evidence for two binding sites
-
Miller G.P., Guengerich F.P. Binding and oxidation of alkyl 4-nitrophenyl ethers by rabbit cytochrome P450 1A2: evidence for two binding sites. Biochemistry. 40:2001;7262-7272.
-
(2001)
Biochemistry
, vol.40
, pp. 7262-7272
-
-
Miller, G.P.1
Guengerich, F.P.2
|